Dr. Emu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 York St
New Haven, CT 06510Phone+1 203-785-4140Fax+1 203-785-3864
Education & Training
- University of California (San Francisco)Fellowship, Infectious Disease, 2001 - 2004
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1998 - 2001
- Johns Hopkins University School of MedicineClass of 1998
Certifications & Licensure
- CT State Medical License 2012 - 2025
- CA State Medical License 2002 - 2012
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 13 citationsPD-1CXCR5CD4peripheral helper T cells promote CXCR3plasmablasts in human acute viral infection.Hiromitsu Asashima, Subhasis Mohanty, Michela Comi, William E Ruff, Kenneth B Hoehn
Cell Reports. 2023-01-31 - 11 citationsSerum Neutralizing Antibody Titers 12 Months After Coronavirus Disease 2019 Messenger RNA Vaccination: Correlation to Clinical Variables in an Adult, US Population.Min Zhao, Rebecca Slotkin, Amar H Sheth, Lauren Pischel, Tassos C Kyriakides
Clinical Infectious Diseases. 2023-02-08 - 154 citationsAssessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A Phase 1 Study.Thomas S. Uldrick, Priscila H. Goncalves, Maher Abdul-Hay, Alisa J Claeys, Brinda Emu
JAMA Oncology. 2019-09-01
Press Mentions
- Ibalizumab Monoclonal Antibody Is Effective in Real-World UseOctober 7th, 2019
- HIV Biologic Drug Reduces Viral Load While Boosting ImmunityAugust 16th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: